Macrogen, Inc.

As of March 31, 2026, Macrogen, Inc. carries a market capitalization of 172.38B, placing it among publicly traded companies globally. Its enterprise value stands at 225.32B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Macrogen, Inc.'s next confirmed earnings release is scheduled for November 18, 2026.

As of March 31, 2026, Macrogen, Inc. has 10.84M shares outstanding.

As of March 31, 2026, Macrogen, Inc. trades at a trailing price-to-earnings ratio of 45.22. The price-to-sales ratio is 0.86, and the price-to-book ratio stands at 1.13.

As of March 31, 2026, Macrogen, Inc. trades at an EV/EBITDA multiple of 82.89 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.13 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 82.89 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 225.32B versus a market cap of 172.38B, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, Macrogen, Inc. maintains a current ratio of 0.79, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended March 31, 2026, Macrogen, Inc. posted a return on equity (ROE) of 2.48, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 0.94 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 1.09, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 2.13, useful for judging operating efficiency across full business cycles. The company generates approximately 392.53M in revenue per employee across its workforce of 508.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 4.83 indicates how many times Macrogen, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, Macrogen, Inc. recorded 268.30M in income tax expense. That works out to an effective tax rate of 11.11, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 2.42B, leaving 3.81B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, Macrogen, Inc.'s stock has declined approximately 26.29% over the past 52 weeks. The 50-day moving average sits at 12,154.00, while the 200-day moving average is 14,331.40.

Over the twelve months ended March 31, 2026, Macrogen, Inc. generated 199.60B in revenue and converted that into 3.81B in net income, yielding earnings per share of 198.03. EBITDA reached 2.72B, while operating income came in at 2.72B.

As of March 31, 2026, Macrogen, Inc. holds 62.61B in cash and equivalents against 100.15B in total debt, resulting in a net debt position of 45.96B. Total book value stands at 151.97B, with working capital of -35.42B providing operational flexibility.

Macrogen, Inc. produced 23.31B in operating cash flow over the twelve months ended March 31, 2026. After subtracting -32.62B in capital expenditures, free cash flow totaled -9.31B - equivalent to -858.41 per share.

Over the twelve months ended March 31, 2026, Macrogen, Inc. posted a gross margin of 36.51, reflecting its pricing power and cost economics. The operating margin of 1.36 and net profit margin of 1.91 provide insight into operational efficiency.

Over the twelve months ended March 31, 2026, Macrogen, Inc. paid dividends of 0.72 per share. The dividend payout ratio of 1.62 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -5.40: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -11.06, meaning Macrogen, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Macrogen, Inc.'s most recent stock split took place on March 18, 2015 with a 2:3 split ratio.

As of March 31, 2026, Macrogen, Inc. has an Altman Z-Score of 1.27, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.